Literature DB >> 33214896

COVID-19: Obesity, deprivation and death.

A Hamish Rw Simpson1, Cameron J Simpson2, Helen Frost3, Susan C Welburn4,5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33214896      PMCID: PMC7648908          DOI: 10.7189/jogh.10.020389

Source DB:  PubMed          Journal:  J Glob Health        ISSN: 2047-2978            Impact factor:   4.413


× No keyword cloud information.
The COVID-19 has disrupted health systems, even within the most developed economies, with case fatality rates in certain countries exceeding 10% [1]. COVID-19 deaths have been linked to diabetes and hypertension [2], which also correlate with obesity. As adipose tissue is prone to infection by the virus and produces high levels of inflammatory cytokines [3], it may feed the cytokine storm [4] suffered by many COVID-19 fatalities suggesting obesity could be the key factor. COVID-19 nation death rates vary greatly, but countries with low obesity rates have consistently low fatality rates; specifically, Thailand, China, South Korea, Japan, and Pakistan are all countries of over 10 million population, but with a national obesity rate of 10% or less [5], which all have less than 50 deaths per million [1]. There are clearly a multitude of factors that contribute to the national death rates. However, countries with obesity rates of over 20% have far more variable mortality rates. The poorest populations are most at risk of chronic conditions, which may put them at risk of dying from COVID19 [5], yet war torn countries such as Syria have not had the exponential increases in deaths observed in Europe and North America; suggesting that when comparing the effect on mortality, of different national strategies for COVID-19, national obesity rates should be considered. National mitigation measures including lockdowns and social distancing may have to extend beyond 2020/21. During this time, individuals have been advised to do mild-to-moderate exercise as it can be of benefit in fighting viral diseases [6]. In addition, individuals should be advised to lose weight (with a mild caloric restriction) to minimise the risk of succumbing to COVID-19. The pressing need for this is illustrated by the analysis of risk factors for critical illness; patients with a BMI>40 had a far higher risk (odds ratio OR 6.2) of requiring hospitalisation [7]. As over one-third of Americans, over one-fifth of Europeans and 13% of the adults in the world are obese [5], a very high percent of the population is at risk of severe symptomatology. Photo: From Hamish Simpson’s own collection, used with permission. Obesity rates rise with economic development of a country [8]. Paradoxically, the relationship of socioeconomic status (SES) to obesity changes, those of higher SES tend to be obese in lower income countries, whereas those of lower SES tend to be obese in high income countries. Thus, poorer individuals in wealthier nations are at particularly high risk of dying from COVID-19, yet due to inequalities, they will have most difficulty in accessing essential life care support. Unfortunately, interventions to prevent transmission have a particularly negative impact on these already impoverished communities. Ethnic minorities have been particularly hard hit by COVID-19, highlighting racial as well as economic inequalities [9]. With COVID-19, economies have been pulled into recession and unemployment rates have spiralled, exhausting national welfare safety nets and placing the burden onto the individual. Yet, those most at risk from this disease are the poorest in society, who have been most impacted by the mitigation strategies and those least able to access health care. Global health promotion strategies should emphasise the benefits of physical activity and weight loss interventions (such as those described by Brown et al [10]) in the fight against this pandemic, and country specific policies need to be developed quickly to support people who are most at risk.
  8 in total

1.  Obesity, SES, and economic development: a test of the reversal hypothesis.

Authors:  Fred C Pampel; Justin T Denney; Patrick M Krueger
Journal:  Soc Sci Med       Date:  2012-01-30       Impact factor: 4.634

Review 2.  Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.

Authors:  John N Fain
Journal:  Vitam Horm       Date:  2006       Impact factor: 3.421

3.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

4.  Low-energy total diet replacement intervention in patients with type 2 diabetes mellitus and obesity treated with insulin: a randomized trial.

Authors:  Adrian Brown; Anne Dornhorst; Barbara McGowan; Omar Omar; Anthony R Leeds; Shahrad Taheri; Gary S Frost
Journal:  BMJ Open Diabetes Res Care       Date:  2020-01

5.  Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic.

Authors:  Livio Luzi; Maria Grazia Radaelli
Journal:  Acta Diabetol       Date:  2020-04-05       Impact factor: 4.280

6.  Why inequality could spread COVID-19.

Authors:  Faheem Ahmed; Na'eem Ahmed; Christopher Pissarides; Joseph Stiglitz
Journal:  Lancet Public Health       Date:  2020-04-02

7.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.

Authors:  Wei-Jie Guan; Wen-Hua Liang; Yi Zhao; Heng-Rui Liang; Zi-Sheng Chen; Yi-Min Li; Xiao-Qing Liu; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Chun-Quan Ou; Li Li; Ping-Yan Chen; Ling Sang; Wei Wang; Jian-Fu Li; Cai-Chen Li; Li-Min Ou; Bo Cheng; Shan Xiong; Zheng-Yi Ni; Jie Xiang; Yu Hu; Lei Liu; Hong Shan; Chun-Liang Lei; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Lin-Ling Cheng; Feng Ye; Shi-Yue Li; Jin-Ping Zheng; Nuo-Fu Zhang; Nan-Shan Zhong; Jian-Xing He
Journal:  Eur Respir J       Date:  2020-05-14       Impact factor: 16.671

8.  Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.

Authors:  Shikha Garg; Lindsay Kim; Michael Whitaker; Alissa O'Halloran; Charisse Cummings; Rachel Holstein; Mila Prill; Shua J Chai; Pam D Kirley; Nisha B Alden; Breanna Kawasaki; Kimberly Yousey-Hindes; Linda Niccolai; Evan J Anderson; Kyle P Openo; Andrew Weigel; Maya L Monroe; Patricia Ryan; Justin Henderson; Sue Kim; Kathy Como-Sabetti; Ruth Lynfield; Daniel Sosin; Salina Torres; Alison Muse; Nancy M Bennett; Laurie Billing; Melissa Sutton; Nicole West; William Schaffner; H Keipp Talbot; Clarissa Aquino; Andrea George; Alicia Budd; Lynnette Brammer; Gayle Langley; Aron J Hall; Alicia Fry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-17       Impact factor: 17.586

  8 in total
  4 in total

1.  The IMPACT of COVID-19 on trauma & orthopaedic surgery provides lessons for future communicable disease outbreaks : minimum reporting standards, risk scores, fragility trauma services, and global collaboration.

Authors:  Andrew J Hall; Nick D Clement; Alasdair M J MacLullich; A Hamish R W Simpson; Tim O White; Andrew D Duckworth
Journal:  Bone Joint Res       Date:  2022-06       Impact factor: 4.410

Review 2.  COVID-19 and metabolic disease: mechanisms and clinical management.

Authors:  Charlotte Steenblock; Peter E H Schwarz; Barbara Ludwig; Andreas Linkermann; Paul Zimmet; Konstantin Kulebyakin; Vsevolod A Tkachuk; Alexander G Markov; Hendrik Lehnert; Martin Hrabě de Angelis; Hannes Rietzsch; Roman N Rodionov; Kamlesh Khunti; David Hopkins; Andreas L Birkenfeld; Bernhard Boehm; Richard I G Holt; Jay S Skyler; J Hans DeVries; Eric Renard; Robert H Eckel; K George M M Alberti; Bruno Geloneze; Juliana C Chan; Jean Claude Mbanya; Henry C Onyegbutulem; Ambady Ramachandran; Abdul Basit; Mohamed Hassanein; Gavin Bewick; Giatgen A Spinas; Felix Beuschlein; Rüdiger Landgraf; Francesco Rubino; Geltrude Mingrone; Stefan R Bornstein
Journal:  Lancet Diabetes Endocrinol       Date:  2021-10-04       Impact factor: 32.069

3.  IMPACT-Global Hip Fracture Audit: Nosocomial infection, risk prediction and prognostication, minimum reporting standards and global collaborative audit: Lessons from an international multicentre study of 7,090 patients conducted in 14 nations during the COVID-19 pandemic.

Authors:  Andrew J Hall; Nicholas D Clement; Cristina Ojeda-Thies; Alasdair Mj MacLullich; Giuseppe Toro; Antony Johansen; Tim O White; Andrew D Duckworth
Journal:  Surgeon       Date:  2022-03-28       Impact factor: 2.632

4.  A Population-Based Registry Analysis on Hospitalized COVID-19 Patients with Previous Cardiovascular Disease: Clinical Profile, Treatment, and Predictors of Death.

Authors:  Eduardo Gutiérrez-Abejón; Francisco Herrera-Gómez; Débora Martín-García; Eduardo Tamayo; Francisco Javier Álvarez
Journal:  J Cardiovasc Dev Dis       Date:  2021-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.